LNA

(redirected from Locked nucleic acid)
Also found in: Wikipedia.
AcronymDefinition
LNALow-Noise Amplifier
LNALocked Nucleic Acid (Link Technologies Ltd.)
LNALinolenic Acid
LNALow Noise Amplifier
LNALinux Network Administration
LNALocal Network Adapter
LNALinux Network Architecture
LNALicensed Nursing Assistant
LNALate Night Alumni (band)
LNALaunch Numerical Aperture
LNALadies National Association
LNALarge Network Administration
LNALion Nathan Australia (foods)
LNALocal Network Attachment
LNALeading National Advertisers, Inc.
LNALost Note Affidavit
LNALogistics Net Assessment
LNALocal National Actions
LNALarge National Account
LNALancaster Neighborhood Association (Waldorf, Maryland)
LNALandWarNet (Land Warrior Network) NetOps (Network Operations) Architecture (US DoD)
References in periodicals archive ?
MRG-110 is a locked nucleic acid modified oligonucleotide inhibitor of microRNA-92.
Respected for his extensive RNA experience and involvement in the Locked Nucleic Acid drug platform, Dr Bo Rode Hansen has authored and co-authored over 40 peer reviewed publications.
In addition to products spanning sample technologies, assay technologies and bioinformatics solutions, Exiqon brings to Qiagen a portfolio of proprietary technologies and know-how used in molecular testing, including relevant Locked Nucleic Acid technology.
The contract has been signed for the expansion of rights to its Locked Nucleic Acid oligonucleotides.
Santaris' Locked Nucleic Acid (LNA) platform is focused on the discovery and development of RNA-targeting therapeutics, a new class of medicines with the potential to address hard to treat diseases.
Scholtka and colleagues used 80 human colon tissue samples representing cancers and precancers to detect genetic variations using a combination of two techniques: The first technique - locked nucleic acid (LNA)-based, wild-type blocking (WTB) polymerase chain reaction - suppressed normal DNA present in large quantities in the sample; and the second technique - high-resolution melting (HRM) - enhanced the detection of genetic variations.
Our results demonstrated that the addition of locked nucleic acid hydrolysis probes specific for pandemic (H1N1) 2009 virus into previously established SYBR green assays can help differentiate segments of pandemic (H1N1) 2009, Eurasian avian-like, and triple reassortant virus lineages.
Separately, Shire has entered into a research-based collaboration with Santaris Pharma A/S, a leading player in RNA-based therapeutics, to develop its proprietary Locked Nucleic Acid technology in a range of rare diseases.
24 August 2009 - Danish biotech company Santaris Pharma A/S said today that UK pharmaceutical company Shire Plc (LON: SHP) will use Santaris's locked nucleic acid (LNA) drug platform to identify and select drug candidates for the treatment of rare genetic disorders.
Among the topics of individual chapters are discovery and development of RNAi therapeutics, locked nucleic acid, morpholinos, applications for inflammatory diseases, and potential applications in ophthalmology.